These studies clearly indicated that a significant proportion of BRD4, but not BRD2 or BRD3, co-eluted with ASXL3/BAP1 complex at approximately 2 M Da within ASXL3-highly expressed SCLC cells (Fig. 2e). Here, BRD2 is linked to small cell lung carcinoma.